Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1

PloS One
Xiao-Bao FanZhi-Ming Hao

Abstract

Transforming growth factor β1 (TGF-β1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over-produced expression of TGF-β1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic fibrosis. In this study, we evaluated the feasibility of attenuating hepatic fibrosis by vaccination against TGF-β1 with TGF-β1 kinoids. Two TGF-β1 kinoid vaccines were prepared by cross-linking TGF-β1-derived polypeptides (TGF-β1(25)-[41-65] and TGF-β1(30)-[83-112]) to keyhole limpet hemocyanin (KLH). Immunization with the two TGF-β1 kinoids efficiently elicited the production of high-levels of TGF-β1-specific antibodies against in BALB/c mice as tested by enzyme-linked immunosorbent assay (ELISA) and Western blotting. The antisera neutralized TGF-β1-induced growth-inhibition on mink lung epithelial cells (Mv1Lu) and attenuated TGF-β1-induced Smad2/3 phosphorylation, α-SMA, collagen type 1 alpha 2 (COL1A2), plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression in the rat hepatic stellate cell (HSC) line, HSC-T6. Vaccination against TGF-β1 with the kinoids significantly suppressed CCl4-induced collagen deposition and the expression of...Continue Reading

References

Jan 1, 1988·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·G BallardiniE Pisi
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W E RussellH L Moses
Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Nov 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F OberhammerR Schulte-Hermann
Jun 1, 1996·Clinical Biochemistry·G K Reddy, C S Enwemeka
Jun 24, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GonzálezA Lage
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z QiH Ueno
May 25, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D ZaguryA Gringeri
Jul 15, 1999·Nature Biotechnology·I DalumS Mouritsen
Sep 17, 1999·The Journal of Biological Chemistry·S S HuangJ S Huang
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·J GeorgeD M Bissell
Jan 25, 2000·The Journal of Biological Chemistry·S L Friedman
Aug 1, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T NakamuraH Ueno
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ZaguryR C Gallo
Feb 7, 2002·Journal of Hepatology·David CassimanTania Roskams
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yutaka YataDon C Rockey
Feb 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GonzalezR Lage
Mar 26, 2003·Cytokine & Growth Factor Reviews·D ZaguryR C Gallo
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lars HolmgrenRolf Kiessling
Dec 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hélène Le BuanecMarie-Christophe Boissier
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Farhad Haghighi RadGeorges Uzan
Feb 7, 2008·European Journal of Immunology·Gunther SpohnMartin F Bachmann
Mar 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elia Neninger VinagerasAgustín Lage Dávila
Apr 25, 2009·Molecular Pharmaceutics·Kun ChengRam I Mahato
Apr 29, 2010·Current Gastroenterology Reports·Alexander James Thompson, Keyur Patel
Jun 20, 2012·The Journal of Pharmacology and Experimental Therapeutics·Zhi-Ming HaoHong-Hong Li

❮ Previous
Next ❯

Citations

Nov 7, 2014·Mediators of Inflammation·Sura Wanessa Santos RochaChristina Alves Peixoto
Feb 26, 2016·Frontiers in Physiology·Ping WangTatiana Kisseleva
Jul 25, 2015·Clinics and Research in Hepatology and Gastroenterology·Yukinori Koyama, David A Brenner
Mar 17, 2017·Canadian Journal of Physiology and Pharmacology·Hong JiYuewen Gong
Jan 15, 2017·BMC Complementary and Alternative Medicine·Mohamed M HafezShakir Dekhal Alsharari
Oct 31, 2014·World Journal of Gastroenterology : WJG·Xue-Ke ZhaoMing-Yu Zhou
Sep 15, 2017·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·D ÖzerkanG Öztürk
May 30, 2014·Experimental Biology and Medicine·Jing ChenBao-Xin Li
Mar 28, 2020·Journal of Food Biochemistry·Mabrouk A Abo-ZaidAhmed H Ismail
Aug 30, 2017·Molecular Medicine Reports·Jun YeQin Du
Aug 3, 2019·Cytotechnology·Yasen AimaitiHao Wen
Jul 1, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Reina SasakiRanjit Ray
Nov 1, 2020·Nature Reviews. Gastroenterology & Hepatology·Tatiana Kisseleva, David Brenner

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modification
ELISA
Assay
reverse transcription PCR
PCR

Software Mentioned

Image
ProPlus

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis